Keyphrases
At-risk
100%
Biological Response
12%
Bladder
62%
Bladder Dose
50%
Clinical Target Volume
100%
Consecutive Patients
12%
Dose Increase
12%
Dose Volume
12%
Equivalent Uniform Dose
12%
Expansion Margin
12%
Intensity-modulated Radiotherapy
100%
Normal Tissue Complication Probability
25%
Pelvic Organs
100%
Planning Target Volume
100%
Post-prostatectomy
100%
Prescription Drugs
12%
Prostate Cancer
12%
Prostate Fossa
37%
Prostatectomy
12%
Radiotherapy Planning
12%
Rectal Dose
50%
Rectal Volume
12%
Rectum
37%
Response Index
12%
Seminal Vesicle
62%
Spearman
12%
Treatment Volume
25%
Volume Expansion
25%
Volume Overlap
25%
Medicine and Dentistry
Bladder
100%
Bladder Capacity
28%
Drug Dose Increase
14%
Intensity Modulated Radiation Therapy
100%
Pelvis
100%
Prostate Cancer
14%
Prostatectomy
14%
Rectal Administration
42%
Seminal Vesicle
71%
Immunology and Microbiology
Bladder Capacity
40%
Drug Dose Increase
20%
Pelvis
100%
Prostate
20%
Rectum
80%
Seminal Vesicle
100%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
33%
Rectal Administration
100%